Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BYON4413
i
Other names:
BYON4413, BYON 4413
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Byondis
Drug class:
CD123-targeted antibody-drug conjugate
Related drugs:
‹
IMGN632 (4)
SGN-CD123A (2)
VIP943 (2)
IMGN632 (4)
SGN-CD123A (2)
VIP943 (2)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
CD123 positive
Acute Myelogenous Leukemia
CD123 positive
Acute Myelogenous Leukemia
BYON4413
Sensitive: D – Preclinical
BYON4413
Sensitive
:
D
BYON4413
Sensitive: D – Preclinical
BYON4413
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login